Browsing Tag

scrutiny

FTC Scrutiny Chills Medtech M&A Market

Medtech M&A has been a bit sluggish this year, and the Federal Trade Commission could be to blame. In a recent analyst report, Neehdam & Co.'s Mike Matson noted that both the number of medtech M&A deals and dollar volume of…

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More